SCHEMBL6174656

SCHEMBL6174656

CC(c1ccnc(-c2ccccc2Cl)c1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
NPBWR1 P48145 1/20 0.35
MCHR1 Q99705 1/20 0.35
LIPE Q05469 5/20 0.35
OPRM1 P35372 1/20 0.35
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
ATP1A1 P05023 1/20 0.33
ATP1B1 P05026 1/20 0.33
ATP1A3 P13637 1/20 0.33
ATP1B2 P14415 1/20 0.33
ATP1A2 P50993 1/20 0.33
ATP1B3 P54709 1/20 0.33
FXYD2 P54710 1/20 0.33
ATP1A4 Q13733 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174848 0.88 LMNA (0.46) LMNALIPEPOLBL3MBTL1ATP1A1
SCHEMBL6175074 0.86 IGF1R (0.37) LMNAAVPR2AVPR1A
SCHEMBL6174788 0.85 LMNA (0.38) LMNANPBWR1MCHR1LIPEOPRM1
SCHEMBL6170257 0.85 IGF1R (0.39) LMNAGPBAR1AVPR2AVPR1A
SCHEMBL6176756 0.84 LMNA (0.42) LMNANPBWR1MCHR1LIPEOPRM1
SCHEMBL6174756 0.83 MAT2A (0.43) LMNANPBWR1MCHR1LIPEPOLB
SCHEMBL6171105 0.83 LMNA (0.39) LMNALIPEPOLBL3MBTL1ATP1A1
SCHEMBL6173438 0.82 LMNA (0.42) LMNANPBWR1MCHR1LIPEPOLB
SCHEMBL6175578 0.82 LMNA (0.42) LMNANPBWR1MCHR1LIPEPOLB
SCHEMBL6177007 0.81 TDP1 (0.42) LMNALIPEPDE2ASLC5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed